Oral corticosteroids in the treatment of ocular myasthenia gravis.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001763:Blepharoptosis / Q000188:drug therapy* / Q000209:etiology; D002675:Child, Preschool; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D004491:Edrophonium; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D009886:Ophthalmoplegia / Q000188:drug therapy* / Q000209:etiology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D004491:Edrophonium; D011241:Prednisone